GeoVax Labs (GOVX) Other Accumulated Expenses (2015 - 2021)
GeoVax Labs (GOVX) posted quarterly Other Accumulated Expenses of $35000.0 for Q3 2021, up 25.8% year-over-year from $27823.0 in Q3 2020, and down 49.53% quarter-over-quarter from $69342.0 in Q2 2021.
GeoVax Labs (GOVX) Other Accumulated Expenses (2015 - 2021) Analysis & Trends
GeoVax Labs (GOVX) has reported Other Accumulated Expenses for 7 consecutive years, with $35000.0 the latest figure, recorded in Q3 2021.
- In Q3 2021, Other Accumulated Expenses rose 25.8% year-over-year to $35000.0; the TTM figure through Sep 2021 stood at $35000.0 (up 25.8% YoY), while the FY2020 annual figure was $79585.0, down 32.75% from the prior year.
- Other Accumulated Expenses fell to $35000.0 in Q3 2021 per GOVX's latest filing, from $69342.0 in the prior quarter.
- Across five years, Other Accumulated Expenses topped out at $125700.0 in Q3 2019 and bottomed at $15000.0 in Q1 2017.
- Historically, Other Accumulated Expenses has averaged $48506.5 across 5 years, with a median of $35000.0 in 2021.
- Annual changes were most pronounced in 2019 — Other Accumulated Expenses jumped 544.09% — and 2020, when it plunged 77.87%.
- GeoVax Labs' Other Accumulated Expenses stood at $18476.0 in 2017, then fell by 0.56% to $18373.0 in 2018, then surged by 544.09% to $118338.0 in 2019, then slumped by 32.75% to $79585.0 in 2020, then sank by 56.02% to $35000.0 in 2021.
- Business Quant data shows GOVX's Other Accumulated Expenses at $35000.0 in Q3 2021, $69342.0 in Q2 2021, and $36623.0 in Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | GeoVax Labs | 2.88 Mn | -260,493.75 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 35,000.00 |
| Jun 30, 2021 | 69,342.00 |
| Mar 31, 2021 | 36,623.00 |
| Dec 31, 2020 | 79,585.00 |
| Sep 30, 2020 | 27,823.00 |
| Jun 30, 2020 | 104,286.00 |
| Mar 31, 2020 | 61,708.00 |
| Dec 31, 2019 | 118,338.00 |
| Sep 30, 2019 | 125,700.00 |
| Jun 30, 2019 | 20,373.00 |
| Mar 31, 2019 | 18,373.00 |
| Dec 31, 2018 | 18,373.00 |
| Sep 30, 2018 | 67,623.00 |
| Jun 30, 2018 | 48,750.00 |
| Mar 31, 2018 | 26,250.00 |
| Dec 31, 2017 | 18,476.00 |
| Sep 30, 2017 | 15,000.00 |
| Jun 30, 2017 | 15,000.00 |
| Mar 31, 2017 | 15,000.00 |
| Dec 31, 2016 | 15,000.00 |